SPI Pharma has been solving formulation challenges using superior functional materials.

Virtual Booth

Contact Supplier

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 Listed Suppliers

1 API Suppliers
1 Listed Suppliers

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

API REF. PRICE (USD/KG)

$ 0

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Regulatory FDF Prices

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

API

FDF

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Lanosterin, Lanster, Botalan base 138, Lanosta-8,24-dienol, (3beta)-lanosta-8,24-dien-3-ol, Kryptosterol

Molecular Formula

C₃₀H₅₀O

Molecular Weight

426.7 g/mol

InChI Key

CAHGCLMLTWQZNJ-BQNIITSRSA-N

FDA UNII

1J05Z83K3M

A triterpene that derives from the chair-boat-chair-boat folding of 2,3-oxidosqualene. It is metabolized to CHOLESTEROL and CUCURBITACINS.

1 2D Structure

Lanosterol

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol

2.1.2 InChI

InChI=1S/C30H50O/c1-20(2)10-9-11-21(3)22-14-18-30(8)24-12-13-25-27(4,5)26(31)16-17-28(25,6)23(24)15-19-29(22,30)7/h10,21-22,25-26,31H,9,11-19H2,1-8H3/t21-,22-,25+,26+,28-,29-,30+/m1/s1

2.1.3 InChI Key

CAHGCLMLTWQZNJ-BQNIITSRSA-N

2.2 Other Identifiers

2.2.1 UNII

1J05Z83K3M

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 4,4,14 Alpha-trimethyl-5 Alpha-cholesta-8,24-dien-3 Beta-ol

2. Kryptosterol

2.3.2 Depositor-Supplied Synonyms

1. Lanosterin

2. Lanster

3. Botalan Base 138

4. Lanosta-8,24-dienol

5. (3beta)-lanosta-8,24-dien-3-ol

6. Kryptosterol

7. Lanosta-8,24-dien-3beta-ol

8. Lanostereol

9. Botalan Base

10. Lanostadien-3-beta-ol

11. Chebi:16521

12. Lanosta-8,24-dien-3-ol, (3.beta.)-

13. Nsc 60677

14. Unii-1j05z83k3m

15. Lanosta-8,24-dien-3-ol, (3beta)-

16. Lanosta-8,24-dien-3-beta-ol

17. Lanosta-8,24-dien-3.beta.-ol

18. 1j05z83k3m

19. Lanosterol [mi]

20. Einecs 201-214-9

21. Nsc-60677

22. (3s,5r,10s,13r,14r,17r)-4,4,10,13,14-pentamethyl-17-[(2r)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-3-ol

23. (3-beta)-lanosta-8,24-dien-3-ol

24. (3.beta.)-lanosta-8,24-dien-3-ol

25. Brn 2226449

26. Ai3-23643

27. Dtxsid1040744

28. 4,4',14alpha-trimethyl-5alpha-cholesta-8,24-dien-3beta-ol

29. Lanosta-8,24-dien-3-ol, (3-beta)-

30. (3beta,20r)-lanosta-8,24-dien-3-ol

31. Cholesta-8,24-dien-3-ol, 4,4,14-trimethyl-, (3beta,5alpha)-

32. Cholesta-8,24-dien-3-ol, 4,4,14-trimethyl-, (3.beta.,5.alpha.)-

33. (3beta,5alpha)-4,4,14-trimethylcholesta-8,24-dien-3-ol

34. 4,4,14alpha-trimethyl-5alpha-cholesta-8,24-dien-3beta-ol

35. (3s,5r,10s,13r,14r,17r)-4,4,10,13,14-pentamethyl-17-((2r)-6-methylhept-5-en-2-yl)-2,3,5,6,7,11,12,15,16,17-decahydro-1h-cyclopenta(a)phenanthren-3-ol

36. Lanosterol [inci]

37. Dtxcid9020744

38. 4,4,14 Alpha-trimethyl-5 Alpha-cholesta-8,24-dien-3 Beta-ol

39. Lanosta-8,24-dien-3beta-ol (8ci)

40. 201-214-9

41. 4-06-00-04188 (beilstein Handbook Reference)

42. Cahgclmltwqznj-bqniitsrsa-n

43. Cahgclmltwqznj-liyszjhcsa-n

44. 79-63-0

45. Cryptosterol

46. Nsc60677

47. 8,24-lanostadien-3beta-ol

48. 3beta-hydroxy-8,24-lanostadiene

49. Lanosterol (technical Grade)

50. Lanostcrol

51. Lanososterol

52. Mfcd00021108

53. Lanosterol - 90%

54. Lanosta-8, (3.beta.)-

55. Lanosterol, >=93%, Powder

56. Schembl145834

57. Chembl225111

58. Gtpl2746

59. Glxc-14819

60. Bdbm50459238

61. Lmst01010017

62. Msk164264

63. S4755

64. (3

65. A)-lanosta-8,24-dien-3-ol

66. (3 Beta)-lanosta-8,24-dien-3-ol

67. Akos024307002

68. Db03696

69. Fl71051

70. Hy-w020033

71. Ncgc00164398-01

72. Fl159528

73. Ms-27534

74. 1st164264

75. Cs-0031956

76. Lanosterol (isocholesterol) - Lanosterol 60%

77. C01724

78. A929846

79. Q414996

80. (3alpha)-4,4,14-trimethyl-cholesta-8,24-dien-3-ol

81. C4ca2f34-1c1a-4673-ac43-e547708cb228

82. Cholesta-8, 4,4,14-trimethyl-, (3.beta.,5.alpha.)-

83. (3beta,5alpha)-4,4,14-trimethyl-cholesta-8,24-dien-3-ol

84. 8,24-lanostadiene-3?-ol;isocholesterol;3?-hydroxy-8,24-lanostadiene

85. (3s,5r,10s,13r,14r,17r)-17-[(1r)-1,5-dimethylhex-4-enyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-3-ol

2.4 Create Date

2004-09-16

3 Chemical and Physical Properties

Molecular Formula	C₃₀H₅₀O
Molecular Weight	426.7 g/mol
XLogP3	8.9
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	1
Rotatable Bond Count	4
Exact Mass	Da
Monoisotopic Mass	Da
Topological Polar Surface Area	20.2
Heavy Atom Count	31
Formal Charge	0
Complexity	767
Isotope Atom Count	0
Defined Atom Stereocenter Count	7
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1